Fonzylane


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 57.7%
Product Used For Unknown Indication 11.1%
Skin Ulcer 7.2%
Ill-defined Disorder 5.3%
Arteritis 2.9%
Unevaluable Event 2.4%
Extrapyramidal Disorder 1.4%
Hypertension 1.4%
Rheumatoid Arthritis 1.4%
Anxiety 1.0%
Arteritis Obliterans 1.0%
Complex Regional Pain Syndrome 1.0%
Epilepsy 1.0%
Juvenile Arthritis 1.0%
Postoperative Analgesia 1.0%
Psoriasis 1.0%
Superinfection Lung 1.0%
Age-related Macular Degeneration 0.5%
Deep Vein Thrombosis 0.5%
Hypothyroidism 0.5%
Epilepsy 15.9%
Gamma-glutamyltransferase Increased 13.6%
Sudden Death 11.4%
Cholestasis 6.8%
Pulmonary Hypertension 6.8%
Death 4.5%
Grand Mal Convulsion 4.5%
Interstitial Lung Disease 4.5%
Skin Hyperpigmentation 4.5%
Somnolence 4.5%
Agranulocytosis 2.3%
Cardiac Arrest 2.3%
Liver Disorder 2.3%
Nausea 2.3%
Neuropathy Peripheral 2.3%
Peripheral Sensory Neuropathy 2.3%
Rash Generalised 2.3%
Rhabdomyolysis 2.3%
Skin Lesion 2.3%
Ventricular Fibrillation 2.3%
Concomitant
Drug Use For Unknown Indication 49.4%
Hypertension 7.8%
Diabetes Mellitus 5.8%
Arthritis 3.7%
Ill-defined Disorder 3.2%
Non-hodgkin's Lymphoma 3.0%
Product Used For Unknown Indication 3.0%
Heart Transplant 2.6%
Osteitis 2.4%
Psoriasis 2.4%
Lymphoma 2.2%
Hypercholesterolaemia 2.1%
Arteritis 1.9%
Dementia Alzheimer's Type 1.9%
Anxiety 1.7%
Arrhythmia 1.5%
Cardiac Failure 1.5%
Dialysis 1.5%
Essential Hypertension 1.3%
Arterial Disorder 1.1%
Thrombocytopenia 15.7%
Renal Failure Acute 12.4%
Renal Failure 6.7%
Vomiting 6.7%
Rectal Haemorrhage 5.6%
Peripheral Ischaemia 4.5%
Toe Amputation 4.5%
Cerebrovascular Accident 3.4%
Dyspnoea 3.4%
Myalgia 3.4%
Oesophageal Ulcer 3.4%
Paraesthesia 3.4%
Parkinsonism 3.4%
Rhabdomyolysis 3.4%
Skin Necrosis 3.4%
Somnolence 3.4%
Transaminases Increased 3.4%
Transitional Cell Carcinoma 3.4%
Vascular Graft Thrombosis 3.4%
Weight Decreased 3.4%

Drug Data